Mizuho Issues Positive Forecast for Quest Diagnostics (NYSE:DGX) Stock Price
Quest Diagnostics (NYSE:DGX – Free Report) had its price objective raised by Mizuho from $178.00 to $189.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently has an outperform rating on the medical research company’s stock. Other equities analysts have also recently issued research reports about the stock. Bank of America upped […]
Quest Diagnostics (NYSE:DGX – Free Report) had its price objective raised by Mizuho from $178.00 to $189.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently has an outperform rating on the medical research company’s stock. Other equities analysts have also recently issued research reports about the stock. Bank of America upped […]